Monthly Archives: October 2012

NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting

Posted on by

SKOKIE, IL--(Marketwire - Oct 11, 2012) - NanoGuardian, a division of NanoInk, Inc. that delivers on-dose brand protection solutions to the pharmaceutical industry to fight counterfeiting and illegal diversion, announced today that it will give a poster presentation at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exhibition, which is being held on October 14 - 18, at McCormick Place in Chicago. The abstract, "Can Nanofabrication be used to Combat Counterfeit Medicines by Applying On-dose Authentication Features without Disrupting the Integrity of the Medicine?" will be presented on Monday, October 15, from 1:30 to 4:30 p.m. in Hall F by Bjoern Rosner, director of research and development, brand protection for NanoGuardian.

"Counterfeit medicines have become such a problem that pharmaceutical manufacturers are evaluating how to best ensure the integrity of their medicines for patients early in the drug development process," said Dean Hart, chief commercial officer of NanoGuardian. "The AAPS poster presentation will demonstrate that NanoGuardian's NanoEncryption technology can be used to incorporate highly sophisticated nanoscale, authentication, and tracing features directly on film-coated tablets, gelatin capsules, and vial caps without affecting the dissolution or stability of the medication -- important considerations in the development and commercialization of a new medication."

NanoGuardian's NanoEncryption technology is the only on-dose, multi-layered, brand protection solution that enables pharmaceutical manufacturers to authenticate and trace every single dose, from plant to patient. NanoGuardian's Closed-Loop Protection Program combines the on-dose authentication and tracing benefits of NanoEncryption technology with a proactive supply chain auditing program to identify counterfeit or illegally diverted pharmaceuticals entering the global supply chain as early as possible.

NanoGuardian fights both counterfeiting and illegal diversion with a single technology that can be used to protect capsules, tablets, vial caps, and single-use syringes providing a layered security of overt, covert, and forensic features. The overt and covert security features allow dose-level authentication at any point in the supply chain, while the forensic and nano-scale NanoCodes provide comprehensive tracing information on each and every dose. NanoGuardian's technology provides a strong benefit over other on-dose technologies given that NanoGuardian's security features are implemented with no additional material or chemicals being added to the medication.

As evidence of the rapidly growing problem of counterfeit pharmaceuticals, a recent report from the U.S. Customs and Border Protection and the U.S. Immigration and Customs Enforcement noted that the domestic value of counterfeit pharmaceutical seizures in fiscal year 2011 rose by more than $11 million, an increase of almost 200 percent. The implications for victims of counterfeit drugs are extremely serious, often resulting in unexpected side effects, severe allergic reactions and even death.

AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to health. It offers timely scientific programs, ongoing education, opportunities for networking, and professional development. More information is available at: http://www.aaps.org.

About NanoGuardian NanoGuardian, a division of NanoInk, Inc., focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting. Anchored by NanoInk's novel NanoEncryption technology, NanoGuardian enables manufacturers to authenticate and trace the integrity of their products across the supply chain. More information about NanoGuardian is available at http://www.nanoguardian.net.

NanoInk, NanoGuardian, NanoEncryption and the NanoGuardian logo are trademarks or registered trademarks of NanoInk, Inc.

Go here to read the rest:
NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting

How 3D Printers Are Reshaping Medicine

Posted on by

Printing off a kidney or another human organ may sound like something out of a science fiction novel, but with the advancements in 3D printing technology, the idea may not be so far-fetched.

BioprintingWhile 3D printing has been successfully used in the health care sector to make prosthetic limbs, custom hearing aids and dental fixtures, the technology is now being used to create more complex structures - particularly human tissue.

Organovo (onvo), a San Diego-based company that focuses on regenerative medicine, is one company using 3D printers, called bioprinters, to print functional human tissue for medical research and regenerative therapies.

"This is disruptive technology," said Mike Renard, Organovo's vice president of commercial operations. "It's always interesting and fun, but never easy."

(More From CNBC: 15 Surprising Global Technology Cities)

Traditional 3D printing, also known as additive manufacturing, is a process of making three dimensional solid objects from a digital model. 3D printing is achieved using additive processes, in which an object is created by laying down successive layers of material such as plastic, ceramics, glass or metal to print an object. Companies including Boeing (ba), General Electric (ge) and Honeywell (hon) use this type of 3D printing to manufacture parts.

Bioprinters, though, use a "bio-ink" made of living cell mixtures to form human tissue. Basically, the bio-ink is used to build a 3D structure of cells, layer by layer, to form tissue.

Eventually, medical researchers hope to be able to use the printed tissue to make organs for organ replacement.

However, growing functional organs is still at least 10 years away, said Shaochen Chen, a professor of nano-engineering at the University of California, San Diego, who uses bioprinting in researching regenerative medicine.

But even though developing functional organs may still be a decade off, medical researchers and others are using bioprinting technology to make advancements in other ways.

Excerpt from:
How 3D Printers Are Reshaping Medicine

Cook Medical’s Zilver® PTX® Trial Shows Sustained Patency after Three Years

Posted on by

LAS VEGAS--(BUSINESS WIRE)--

Three-year data from the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease from Cook Medical demonstrate 70.7 percent primary patency in the superficial femoral artery (SFA) at 36 months for patients treated with the paclitaxel-eluting stent. This compares to 49.1 percent patency for patients with percutaneous transluminal angioplasty and provisional bare metal stent placement in the 479-patient study.

In addition, the paclitaxel coating was shown to reduce the restenosis rate by 53 percent in a head-to-head comparison of provisional paclitaxel-eluting versus bare metal stent placement.

Michael Dake, M.D., professor in the Department of Cardiothoracic Surgery at Stanford University Medical School and medical director of the Cath/Angio Laboratories at Stanford University Medical Center, Palo Alto, California, presented the study findings yesterday at the Vascular InterVentional Advances (VIVA) 2012 conference in Las Vegas, Nev.

These data, from the largest clinical study ever conducted on peripheral stenting, clearly show a sustained drug effect for paclitaxel-eluting stents versus bare metal stents after three years, said Rob Lyles, vice president and global leader of Cook Medicals Peripheral Intervention clinical division. We are proud to have pioneered this important technology.

Zilver PTX is neither approved by U.S. Food and Drug Administration nor available for sale in the United States. Dr. Dake, the global principal investigator for the Zilver PTX trial, is a paid consultant to Cook Medical regarding the research and development of medical devices.

About Cook Medical

A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. For more information, visit http://www.cookmedical.com. Follow Cook Medical on Twitter and LinkedIn.

Read the original post:
Cook Medical’s Zilver® PTX® Trial Shows Sustained Patency after Three Years

Programs pay off medical school debt

Posted on by

Share this story:

In Colorado, there is a serious need for primary care doctors both in rural areas and in Colorado Springs. The National Health Service Corps and the Colorado Health Service Corps are trying to address the need through loan forgiveness grants to medical school students.

The National Health Service Corps granted more than $12 million in student loan forgiveness during 2011 in Colorado and contracted with 240 primary care providers to erase medical school debt and get more doctors in rural areas. The CHSC gave more than $2.5 million to nearly 80 primary care doctors.

So far this year, NHSC granted $2.8 million in loan repayment funding to graduating doctors in the state. In exchange, the new doctors agree to work at community health centers like Peak Vista Community Health Centers, serving an underinsured and indigent population.

The Health Service Corps has been incredibly successful in helping us attract health care professionals to Community Health Centers, said Tanah Wagenseller, health center workforce manager for Colorado Community Health Network. Its helping students who want to make a difference find a job where they can do that every day.

The National Health Service Corps was created 40 years ago to provide rural areas with essential health services, and receives bipartisan support from Congress. The federal government doubled the program in 2009, after recognizing the upcoming shortage of primary care physicians.

The Colorado Health Service Corps offers providers more flexibility and is administered through the Department of Public Health and Environment with funding from the Colorado Health Foundation, the U.S. Health Resources and Services administration, the American Recovery and Reinvestment Act, the state of Colorado, the Colorado Trust and the Comprecare Foundation.

Despite the programs success, there is still a stark need for new primary care doctors. Colorado has 3,200 licensed primary care physicians, and many are nearing retirement age, while an increasing percentage of medical students are choosing other specialties. Some 85 percent of the state is deemed a professional health shortage area.

At the same time, safety net sites that provide health care expect increased demand as aresult of health care reform. One in 10 people in Colorado depend on a community health center for primary care. That number is expected to grow dramatically when health reform is fully implemented in 2014, expanding access to care to about 540,000 residents.

More here:
Programs pay off medical school debt

Our View: Community needs to show support for Central Michigan University Medical School in Saginaw

Posted on by

The following is the view of The Saginaw News Editorial Board on the plans for Central Michigan University's medical school campus in Saginaw.

Central Michigan Universitys medical school presence in Saginaw is no longer a pipe dream.

With more than $16 million raised in the $25 million campaign for two Saginaw locations, CMU officials say the pieces are in place to start construction next fall and have students here in 2014.

The partnerships with Covenant HealthCare and St. Marys of Michigan, along with affiliations with 17 hospitals throughout Mid-Michigan, can only mean good things for the future of healthcare in the area.

CMU medical students will spend the last two years of medical schooling locally, practicing at our facilities. Not only will we help train the future doctors of America, but school officials expect many of them will make this region their home and continue to offer quality health care to local residents. The school will also provide an opportunity for Michigan residents to attend medical school in their home state officials say preference will be given to Michigan applicants.

CMU officials were in town last week to update business leaders on the project and allay fears that it wouldnt happen.

The project didnt have the most stellar start when CMUs former president Michael Rao left the university less than a year after it was announced and the medical schools first choice for dean resigned the position.

We believe there has been so doubt that this was going to become a reality, said Kathleen Wilbur, CMUs vice president of development and external affairs, during a meeting with The Saginaw News Editorial Board It is more than reality at this point.

And with drawings of the two Saginaw buildings in hand, accreditation underway and more than half the money raised for the campaign, the momentum is building. It is time now for the community to throw all we have into this and make it happen.

With about $10 million left in the fundraising goal, wed love to see governments in the entire region work with CMU to secure grant funding and private donors step up to the plate to bring in the money.

Continued here:
Our View: Community needs to show support for Central Michigan University Medical School in Saginaw

Engineered flies spill secret of seizures

Posted on by

ScienceDaily (Oct. 11, 2012) Scientists have observed the neurological mechanism behind temperature-dependent -- febrile -- seizures by genetically engineering fruit flies to harbor a mutation analogous to one that causes epileptic seizures in people. In addition to contributing the insight on epilepsy, their new study also highlights the first use of genetic engineering to swap a human genetic disease mutation into a directly analogous gene in a fly.

In a newly reported set of experiments that show the value of a particularly precise but difficult genetic engineering technique, researchers at Brown University and the University of California-Irvine have created a Drosophila fruit fly model of epilepsy to discern the mechanism by which temperature-dependent seizures happen.

The researchers used a technique called homologous recombination -- a more precise and sophisticated technique than transgenic gene engineering -- to give flies a disease-causing mutation that is a direct analogue of the mutation that leads to febrile epileptic seizures in humans. They observed the temperature-dependent seizures in whole flies and also observed the process in their brains. What they discovered is that the mutation leads to a breakdown in the ability of certain cells that normally inhibit brain overactivity to properly regulate their electrochemical behavior.

In addition to providing insight into the neurology of febrile seizures, said Robert Reenan, professor of biology at Brown and a co-corresponding author of the paper in the Journal of Neuroscience, the study establishes

"This is the first time anyone has introduced a human disease-causing mutation overtly into the same gene that flies possess," Reenan said.

Engineering seizures

Homologous recombination (HR) starts with the transgenic technique of harnessing a transposable element (jumping gene) to insert a specially mutated gene just anywhere into the fly's DNA, but then goes beyond that to ultimately place the mutated gene into exactly the same position as the natural gene on the X chromosome. HR does this by outfitting the gene to be handled by the cell's own DNA repair mechanisms, essentially tricking the cell into putting the mutant copy into exactly the right place. Reenan's success with the technique allowed him to win a special grant from the National Institutes of Health last year.

The new paper is a result of that grant and Reenan's collaboration with neurobiologist Diane O'Dowd at UC-Irvine. Reenan and undergraduate Jeff Gilligan used HR to insert a mutated version of the para gene in fruit flies that is a direct parallel of the mutation in the human gene SCN1A that causes febrile seizures in people.

When the researchers placed flies in tubes and bathed the tubes in 104-degree F water, the mutant fruit flies had seizures after 20 seconds in which their legs would begin twitching followed by wing flapping, abdominal curling, and an inability to remain standing. After that, they remained motionless for as long as half an hour before recovering. Unaltered flies, meanwhile, exhibited no temperature-dependent seizures.

The researchers also found that seizure susceptibility was dose-dependent. Female flies with mutant strains of both copies of the para gene (females have two copies of the X chromosome) were the most susceptible to seizures. Those in whom only one copy of the gene was a mutant were less likely than those with two to seize, but more likely than the controls.

Continue reading here:
Engineered flies spill secret of seizures

Gene Deletion Linked to Mental Illness, Obesity

Posted on by

By Traci Pedersen Associate News Editor Reviewed by John M. Grohol, Psy.D. on October 11, 2012

Researchers have pinpointed a small region in the genome the entirety of human hereditary information as a vital factor in the development of psychiatric disease and obesity.

Brain-derived neurotrophic factor, or BDNF, is a nervous system growth factor that plays a critical role in brain development. To determine the role of BDNF in humans, McGill researchers screened over 35,000 people referred for genetic screening at clinics, as well as over 30,000 control subjects in the U.S., Canada and Europe.

Researchers found five individuals with BDNF deletions, all of whom were obese, had a mild-moderate intellectual impairment, and had a mood disorder.

The children had anxiety disorders, aggressive disorders, or attention deficit-hyperactivity disorder (ADHD), while post-pubescent individuals had anxiety and major depressive disorders. Subjects slowly gained weight with age, suggesting that obesity is a long-term process when BDNF is deleted.

The results of the new study, published in the Archives of General Psychiatry, reveal for the first time the link between BDNF deletion, cognition, and weight gain in humans.

Scientists have been trying to find a region of the genome which plays a role in human psychopathology, searching for answers anywhere in our DNA that may give us a clue to the genetic causes of these types of disorders, saidCarl Ernst, Ph.D., from McGills Department of Psychiatry, Faculty of Medicine.

Our study conclusively links a single region of the genome to mood and anxiety.

Based on animal studies, BDNF has been a suspect of several functions in the brain, but no study has proven what happens when BDNF is missing from the human genome. The new study helps provide a better understanding of human behavior and mood by clearly identifying genes associated with mental disorders.

Mood and anxiety can be seen like a house of cards. In this case, the walls of the house represent the myriad of biological interactions that maintain the structure, said Ernst, who is also a researcher at the Douglas Mental Health University Institute.

Read more:
Gene Deletion Linked to Mental Illness, Obesity

Finley says chemistry still an issue

Posted on by

GREEN BAY, Wis. -- The relationship between Packers quarterback Aaron Rodgers and tight end Jermichael Finley frequently boils down to one word: chemistry.

In Finley's mind, chemistry between the two is often directly related to his personal statistics and those of the offense as a whole. With Green Bay's 2-3 record and an offense ranked 21st in the NFL in total yards and 18th in scoring, Finley believes his chemistry with Rodgers has a ways to go.

"It's OK," Finley said Wednesday. "Not good enough at all. Something to be worked on, and try to work on it as much as I can, try to talk to him as much as I can, but like I said, it takes two people."

Finley dislocated the AC joint in his right shoulder in Sunday's loss to the Colts, but he is still hoping to play this weekend when the Packers are in his home state to face the undefeated Houston Texans.

Considering that he'll be playing injured if he's cleared for the game, Finley was asked whether he can take his game to the level he wants with his shoulder the way it is.

"I can, (but) it takes two people to do that," Finley said. "And I need the quarterback on my side, and I need to catch the ball when he throws it to me. So it takes two things to get that going, the chemistry. I feel we need to get that going."

This is far from the first time Finley has raised the issue of chemistry between he and the reigning NFL MVP.

"I'm not blaming it on my offseason, but me and the QB didn't have chemistry," Finley said on June 1 following Green Bay's first OTA practice. "The routes were off sometimes, and that'll mess with your head when the ball comes."

Later in that same interview, Finley added: "I couldn't get the chemistry with the QB."

Finley, who signed a two-year, $15 million extension this offseason, is on pace for 134 fewer receiving yards than a year ago. Through five games, Finley has 22 catches for 198 yards with one touchdown and one fumble. According to ProFootballFocus.com, Finley also has five drops this season.

Excerpt from:
Finley says chemistry still an issue

6th International Meeting on Biotechnology held at Bilbao Exhibition Centre (BEC), in Barakaldo (Bilbao), from 19 to …

Posted on by

MADRID, October 11, 2012 /PRNewswire/ --

BioSpain 2012 is now the world's fourth-largest business development event in biotechnology

The final figures show BioSpain 2012 was a major success and evidence the growing importance of biotechnology in Spain.

In fact, this year BioSpain climbed to fourth place worldwide among biotechnology business development/partnering events, having hosted a total of 2,775 meetings, a 29% increase on the previous edition in 2010. Consequently, BioSpain 2012 jumped from 7th to 4th place, with a percentage gain in excess of those registered by BIO International Convention (21,183 meetings, +23%), BIO Europe (14,765 meetings, +1%) and BIO Europe Spring (11,172 meetings, 24% more).

This sixth edition of BioSpain experienced an overall increase in participants: 1,850 industry professionals from Spain and other countries came to the Bilbao Exhibition Centre (BEC) in Barakaldo between 19 and 21 September, i.e. 32% more than in the previous edition (2010, in Pamplona).

The event was inaugurated by HRH The Prince of Asturias, who toured the trade fair to discover the latest developments in the industry. He then met with people in the industry, from both business and research, expressing his absolute support for the biotechnology sector and his intention to attend future editions if his schedule permitted.

The trade fair was 50% larger this year in terms of floor space, and there were 217 exhibitors, 29% more than in 2010; 78% were Spanish firms, 22% international firms.

A new feature this year was the Biotechnology Career Fair, aimed at matching supply and demand of labour in the biotechnology industry. A total of 400 people registered. The vacancies were mainly in science and in business development, although other areas of expertise in biotech were also in demand. The majority of job seekers were graduates or PhDs with experience or a background in health-related ("red") biotechnology.

The international nature of this fair was evidenced by the 40% increase in the number of participating international firms with respect to the 2010 edition. A total of 762 companies participated, 210 from other countries (28% of the total). The number of international firms exhibiting in the trade fair increased by 65.5% (to 48). The breakdown of international companies was as follows: UK (6%), France (4%), Germany (2%), United States (2%), Belgium (2%), Switzerland (2%), Netherlands ( 1%), Portugal (1%), Italy (1%) and Mexico (1%).

The 6th International Meeting on Biotechnology, BioSpain 2012 (http://www.biospain2012.org), a biennial event organised by ASEBIO, the Spanish Association of Biotechnology Companies, in cooperation this year with Society for Competitive Transformation (SPRI), an agency of the Basque government, beat the record figures set at the previous edition, which was held in Pamplona in 2010. It achieved its main goal of expanding the presence of foreign participants and creating a suitable framework for business development for both Spanish and foreign companies and institutions.

Original post:
6th International Meeting on Biotechnology held at Bilbao Exhibition Centre (BEC), in Barakaldo (Bilbao), from 19 to ...

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

Posted on by

NEW YORK, Oct. 11, 2012 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p01009677/Nanoparticles-in-Biotechnology-Drug-Development-and-Drug-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Nanotechnology

REPORT HIGHLIGHTS

-The global market for nanoparticles in biotechnology, drug development and drug delivery was valued at $17.5 billion in 2011 and should reach nearly $21.6 billion in 2012. Total market value is expected to reach $53.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.9%.-Drug delivery systems are expected to increase from $11.3 billion in 2012 to $30.9 billion in 2017, a CAGR of 22.2%.-Drug development and formulation should total nearly $9.4 billion in 2012 and nearly $20.5 billion in 2017, a CAGR of 16.9%.

STUDY GOALS AND OBJECTIVES

This study provides a comprehensive analysis of the market for nanoparticles in the life sciences on a global basis. Particular attention is given to drug development and formulation and the development of new drug delivery systems. Its aim is to provide a range of information, from detailed product analyses within health and wellness subsegments to overall industry trends in order to quantify and qualify the market for drug products for treating various disease conditions in both men and women. The applicability of specific types of nanoparticles for specific applications is discussed.

Forecasts and trends are developed from a cross-reference of data points gleaned from proprietary industry sources, company publications, industry benchmarking and other divergent data sources to arrive at a cogent and coordinated forecast.

The nanoparticle drug/delivery market presents an increasingly significant part of the overall pharmaceutical product market worldwide. This study investigates the specific classes of nanoparticles and the pharmaceutical products associated with them. Existing drug products and potential drugs in the pipelines of the major pharmaceutical players in this market are reviewed. Growing health concerns in developing countries are expected to continue to contribute substantially to market growth through the forecast period (2012 through 2017). This report analyzes emerging markets by technology category. Continued growth is expected in emerging geographies driven by the health awareness of the growing middle class in emerging countries such as India, China, Brazil and Russia.This report seeks to address the critically important topics of analyzing a changing market dynamic, emerging players and products, strategies for accessing emerging markets and awareness of specific disease prevalence and geographies thereof in order to allocate resources and make effective decisions.

SCOPE OF REPORT

Current and projected product forecasts during the forecast period of 2012 through 2017 are discussed. New product launches will be discussed. Revenue figure for 2011 are in an actual figures except where actual results have not been reported due to the timing of this report's release.

Read the original:
Nanoparticles in Biotechnology, Drug Development and Drug Delivery

AIS professor triggered red alert on Armstrong blood cells

Posted on by

IT WAS the work of Australian Institute of Sport head of physiology Professor Christopher Gore that determined the chances of Lance Armstrong being clean in the 2009 and 2010 Tour de France races.

Professor Gore examined blood samples taken from Armstrong between October 2008 and April this year for the US Anti-Doping Agency - 29 samples taken by the World Anti-Doping Agency and a further nine taken by USADA.

According to the USADA report on Armstrong, a cluster of five Armstrong samples taken during the 2009 Tour and his two samples during the 2010 event contained an unusually low percentage of reticulocytes, or immature red blood cells that are created naturally by the body. When an athlete adds additional red blood cells to his circulation by transfusing his own stored blood, the body's production of reticulocytes is suppressed.

''When Prof Gore compared the suppressed reticulocyte percentage in Armstrong's 2009 and 2010 Tour de France samples to the reticulocyte percentage in his other samples, Prof Gore concluded that the approximate likelihood of Armstrong's seven suppressed reticulocyte values during the 2009 and 2010 Tours de France occurring naturally was less than one in a million," the report said.

Advertisement

Professor Gore was unavailable for comment yesterday, but AIS director Matt Favier had nothing but praise for his work.

"Professor Gore has worked at the Australian Institute of Sport for more than 20 years and is the head of the department of physiology. Professor Gore earned his PhD in 1989 and has published over 130 papers,'' Favier said. ''He has two professorships and is well positioned as an internationally recognised expert.

"Given his expertise and impeccable credentials, Professor Gore has provided an evidence-based opinion on perturbation in various factors found in the blood of athletes in several anti-doping cases.

"Professor Gore was also a key researcher in work prior to the Sydney Olympic Games that provided the basis for the current process that identifies abnormal levels of markers in an athlete's bloodstream. Moreover, the basic model of the so called 'athlete blood passport' now used by WADA and USADA is built on the foundation of that 1999-2000 research project, which was funded by the IOC.''

Australia has several links to Armstrong. He made his racing comeback in January 2009 at the Tour Down Under in Adelaide, and then last year, he raced professionally for the final time in the same event.

View original post here:
AIS professor triggered red alert on Armstrong blood cells

Digital Pathology Market – Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes …

Posted on by

NEW YORK, Oct. 11, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Digital Pathology Market Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & Whole Slide Image Storage - Global Trends & Forecast Till 2017

http://www.reportlinker.com/p01009588/Digital-Pathology-Market--Slide-Scanners-Whole-Slide-Imaging-Analytics-Image-Analysis-Software-Delivery-Modes-Web-Based/Cloud-Based--Whole-Slide-Image-Storage---Global-Trends--Forecast-Till-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

The life science industry is now witnessing the second decade of "Biologic Revolution". The adoption and up gradation of technology is increasing rapidly. Conventional practices are being replaced by advanced technologies. The perception of pathological laboratories needs to be improved as the consumer expectations and government regulations towards improved patient safety, accurate diagnosis, Electronic Medical Records (EMR) as well as personalized medicines are growing. Pathology plays a significant role in patient care. Digital pathology serves this purpose by providing a facility for digital transformation of pathology and laboratory medicine.

Digital pathology is currently gaining momentum as pathologists are seeking to achieve workflow efficiency and cost cutting in the pathological process. It provides ready access to premium quality slide images, enabling better and fast diagnosis, as well as preservation of these digital slides for future reference. The digital pathology market is driven by the factors such as reduction in laboratory expenses, improvement in operational efficiency, and treatment decisions and patient care. The rising prevalence of cancer, increasing trends in drug development, companion diagnostics, and ease of consultation are the major drivers that are slated to propel this market. However, a few pivotal factors restraining the growth of this market are FDA regulations in some regions, high cost of Digital Pathology Systems (DPS), technological problems, and conservative outlook of pathologists. There are a few well-established firms and several small ones operating in this industry. The major players in the market are Aperio Technologies, Inc. (U.S.), Ventana Medical Systems (U.S.), Leica Microsystems GmbH (Germany), Digipath (U.S.), and Hamamatsu Photonics (Japan).

The global digital pathology market is broadly segmented into two categories based on its products and application. The product category includes scanners, analytics (visualization software, information management systems and image analysis platforms), storage and communication (sharing services, software), while the application category comprises human pathology and animal pathology. Both these markets are dominated by North America in 2012, followed by Europe, Asia, and Rest of the World (RoW). The global digital pathology market is estimated to be $191.00 million in 2012, and is poised to grow at a CAGR of 12% to reach $336.61 million by 2017.

The global digital pathology market is dominated by the North America, followed by Europe, Asia, and Rest of the World. North America will continue to lead the digital pathology market for the next five years in spite of stringent FDA regulations and premarketing approvals. This is due to the increasing adoption of digital pathology systems by research labs, pharmaceutical and biotechnology companies, clinical research institutes, contract research organizations, etc. Moreover, the capacity to spend money is also driving the growth in this geography. However, a robust growth rate will be observed in Europe as vendors and manufacturers will be seen turning towards the region for regulatory reliefs. The Asian region's contribution to the global digital pathology market is also expected to pick up in the coming years, as the technology gets more recognition and becomes more cost effective.

Scope of the Report

This research report categorizes the global digital pathology market into different segments based on its products and application.

Global digital pathology market, by products

Original post:
Digital Pathology Market - Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes ...

The International Youth Conditioning Association Runs Promotion on its Youth Nutrition Specialist Certification …

Posted on by

The worlds leading youth fitness organization, the International Youth Conditioning Association, is running a promotion on its Youth Nutrition Specialist Certification. The promotion is currently underway and ends Friday, October 12th at Midnight EST.

Elizabethtown, KY (PRWEB) October 10, 2012

The IYCA, the worlds leading youth fitness organization, is offering the nutrition certification after years of experience working with coaches and trainers who have expressed a desire to push their young athletes to the next level in areas beyond mere youth sports training.

A lot of youth fitness trainers and coaches come to us because they dont know how to take the next step when it comes to young athlete development, says Pat Rigsby, co-owner and CEO of the International Youth Conditioning Association.

What many youth sports coaches and trainers fail to understand is that athletes might not have people monitoring what they eat, Rigsby continues. Kids need to be taught proper nutrition, because in our society its very easy to be tempted to eat poorly.

Rigsby, a former college baseball coach, notes that trainers express reservations about branching into other areas of young athlete development beyond exercise and sports. Trainers shouldnt be content to just make exercise programs for kids, Rigsby says. Kids fitness is about developing the entire athlete.

One of the major concerns trainers have voiced is that there is not enough time during youth sports training sessions to address nutritional concerns. However, Rigsby notes that a good trainer will carve out time to address concerns that affect youth sports performance.

In fact, children often look to their coaches for any information that would help them with sports performance, including diet.

One final concern that plagues youth sports coaches is that they simply do not have the expertise to advice children on proper nutrition.

This is a valid concern, Rigsby admits. However, that is the entire purpose for the IYCAs Youth Nutrition Specialist Certification. We want to teach trainers and coaches how to instill proper eating in their young athletes.

See the original post here:
The International Youth Conditioning Association Runs Promotion on its Youth Nutrition Specialist Certification ...

Dietitian Wins Nutrition Award to be Breast Feeding Expert

Posted on by

11 October 2012

Dietitian Wins Nutrition Award to Become Breast Feeding Expert

A dietitian from North Shore Hospital has won a prestigious nutrition award to support her career ambition to be the first New Zealand dietitian specialising in breast feeding.

Sarah-Jane Westbrooke became a New Zealand Registered Dietitian in 2009 and currently works as a Paediatric Dietitian at North Shore Hospital, where her main professional interest area is neonatal and infant nutrition. She will use the New Zealand Nutrition Foundation and Kellogg New Zealand 2012 Nutritionist Development Award for the training needed to become a New Zealand dietitian with specialist knowledge in breastfeeding. In the longer term Sarah-Jane aims to become the first New Zealand Registered Dietitian and Lactation Consultant.

A Rotary Group Study Exchange to Alaska/Yukon earlier this year fuelled her ambition. Sarah-Jane saw dietitians there working closely with the maternity and child health sector to promote optimum nutrition from pre-conception, through pregnancy, breastfeeding and childhood. I came back inspired, Sarah-Jane says. I saw how dietitians with specialist knowledge in lactation can improve the health services provided to mothers and babies. I want to do the same in New Zealand.

Sue Pollard, CEO of the New Zealand Nutrition Foundation, says the Foundation is pleased to be able to give the award this year in line with the New Zealand Health Workforce Strategy of improving the efficacy and efficiency of health services provided to mothers and babies in New Zealand. This is an investment in the future health of our population, she says.

Julian Ng, Marketing Manager, Kellogg New Zealand says this award helps to recognise and support the outstanding local talent starting out on their career in nutrition. Sarah-Jane is clearly a highly talented and dedicated dietitian. Kelloggs is delighted to be supporting her proposed learning and innovative approaches in the field of nutrition to help further impact the well-being of New Zealanders, says Ng.

Kelloggs has been a long term supporter of the Nutritionist Development Award, which was first established in 1995 to promote professional development for those in New Zealand working in the field of nutrition.

About Kelloggs

Kelloggs is a leading producer of breakfast cereals and a leading producer of grainbased snack foods. Kelloggs cereal has been part of Kiwi breakfasts since 1929 and has established a strong presence with brands like Nutri-Grain, Coco Pops, Sultana Bran, Special K, Just Right, Corn Flakes and Rice Bubbles to name a few.

See the original post:
Dietitian Wins Nutrition Award to be Breast Feeding Expert

Top researchers unpack today's hottest nutrition trends at national symposia

Posted on by

Fact or fad? Canadians might be surprised.

MONTREAL, Oct. 11, 2012 /CNW/ - Leading academics and researchers will reveal their latest findings to health professionals next week in Vancouver, Toronto, Montreal and Moncton at a series of symposia titled "Controversations: Discussing timely food and nutrition issues" organized by Registered Dietitians at Dairy Farmers of Canada. They will reveal surprising new research on some of today's most controversial food and nutrition trends. Topics and speakers include:

"Thousands of Canadians have heard about these nutrition and food related issues and are looking for accurate, up-to-date information," said Nathalie Savoie, assistant director, nutrition, with Dairy Farmers of Canada. "The team of Registered Dietitians at Dairy Farmers of Canada is pleased to organize these symposia to equip health professionals with science-based evidence from the world's top experts to allow them to provide guidance and advice to their patients."

Dairy Farmers of Canada The information provided by our panel of experts is designed to equip health professionals across Canada with the latest information and best available evidence regarding the role of milk products in a healthy diet. The team of dietitians at Dairy Farmers of Canada promotes the wholesome goodness of milk products as part of healthy eating patterns and encourages good nutrition for all Canadians.

Continue reading here:
Top researchers unpack today's hottest nutrition trends at national symposia

Driven Sports and Predator Nutrition Gear up for the Arnold Classic Europe EXPO

Posted on by

BRADFORD, England, October 11, 2012 /PRNewswire/ --

Fitness fanatics heading to Madrid this weekend for the Arnold Classic Europe EXPO are being urged to check out the Driven Sports exhibition stand to discover more about the leading sports nutrition manufacturer.

With the help of Predator Nutrition, a leading distributor and retailer of dietary supplements, Driven Sports are hoping to raise their profile in Europe, with the upcoming event in Spain the perfect opportunity for bodybuilders and fitness enthusiasts to meet the team and find out about their product range.

The Arnold Classic originally started out as a bodybuilding content in Ohio and has since been expanded into a weekend packed with sporting competition including everything from boxing to gymnastics, launching a European version last year.

For Matt Cahill, Driven Sports VP of Operations, and Reggie Johal, Predator Nutrition President and Founder, the Arnold Classic Europe EXPO represents an exciting three days.

Cahill commented: "We are slowly building a presence in the UK and Europe.

"With the assistance of Predator Nutrition we are really excited to see just how much we can grow in this territory."

Predator Nutrition is the official European distributor of Driven Sports and Johal added: "Driven Sports are one of our most popular brands, and Craze is our biggest selling product of all-time.

"The Arnold Classic Europe EXPO is the perfect opportunity to showcase Driven Sports, and particularly Craze, to anyone that is not familiar with them."

Predator Nutrition will be running a variety of special offers throughout the three days and you can follow them on Twitter and Facebook for the latest news and deals.

See the article here:
Driven Sports and Predator Nutrition Gear up for the Arnold Classic Europe EXPO

Research and Markets: Medical Nutrition – A Global Market Overview

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/6p5gfv/medical_nutrition) has announced the addition of the "Medical Nutrition - A Global Market Overview" report to their offering.

Global Medical Nutrition Market to Reach $29 billion in 2013

An increase in aging populations coupled with growing incidences of illnesses and a condition requiring medical nutrition products has resulted in market growth for medical nutrition products. Another key factor that driving the market is premature births because of insufficient nutrition supply to mothers, especially in Asia, in most populous countries such as China and India. However, medical nutrition products that contain probiotics and prebiotics, primarily targeted at the aging population, are witnessing unprecedented demand as against traditional medical nutrition products, opening the gates for a new market dominated by very few players.

Medical Nutrition product segments analyzed in this study include Infant, Enteral and Parenteral. The report also analyses the sub-segments of Enteral Medical Nutrition comprising Standardized, Elemental/Semi-Elemental and Specialized Entetal Nutrition. The global market for Medical Nutrition, estimated at US$27.2 billion in 2012 and forecast to be US$28.8 billion in 2013, is further projected to reach US$40.1 billion by 2018, thereby exhibiting a 2008-2018 CAGR of 5.8%.

"Medical Nutrition - A Global Market Overview" reviews and analyses the worldwide market for medical nutrition products for the global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 15 independent countries across North America - the United States, Canada and Mexico; Europe - Germany, France, the United Kingdom, Italy, Spain and Rest of Europe; Asia-Pacific - Japan, China, India, South Korea and Rest of Asia-Pacific; South America - Brazil, Argentina and Rest of South America.

This 387 page global market report includes 180 rich data tables, supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value by geographic regions, product segments/sub-segments. This market report covers the brief business profiles of 25 key global players and 46 major players across North America - 28; Europe - 12; and Asia-Pacific - 6.

The report also provides the listing of the companies that are engaged in manufacturing, research and development, processing, supplies and distribution of Medical Nutrition products. This global list includes the addresses, contact numbers and the website addresses of 220 companies.

Examples of Companies Mentioned:

- Abbott Nutrition

The rest is here:
Research and Markets: Medical Nutrition - A Global Market Overview

Liquid Nutrition Signs Trish Stratus To Team Liquid

Posted on by

TORONTO--(BUSINESS WIRE)--

Liquid Nutrition Group Inc. (Liquid Nutrition or Company) (TSX-V: LQD.V and LQD.WT) announced today fitness icon, actress and entrepreneur Trish Stratus has joined Team Liquid.

Liquid Nutrition continues to attract and partner with some of the biggest, brightest and healthiest stars. Stratus is recognized as one of the top sports entertainment athletes in the world through her achievements with WWE as a seven-time Womens Champion.

Its a natural partnership for Liquid Nutrition and myself, said Stratus from her Stratusphere Yoga Studio in Vaughan, Ontario. The brand truly aligns with how I live my life on a day-to-day basis, Im excited to be apart of Team Liquid and promote a healthy and active lifestyle.

Glenn Young, President, Liquid Nutrition Group Inc. is thrilled with the latest addition to Team Liquid.

Trish is committed to achieving wellness through balanced living, this is something many Liquid Nutrition customers also strive for. Trish will be an inspirational and motivational ambassador for fans of Team Liquid, said Young.

The partnership will see Stratus become an equity partner of Liquid Nutrition and Liquid Nutrition becomes an official sponsor of Stratusphere Yoga Studio.

In her role, Stratus will promote the Liquid Nutrition brand along with her fellow Team Liquid members and also serve as a fitness and health and wellness consultant.

Comprised of pro-athletes and experts in the world of sports, fitness and nutrition, members of Team Liquid are selected based on their personal and professional dedication to healthy active living.

Stratus joins existing Team Liquid members: Steve Nash (NBA), Torah Bright (snowboarding), Russell Martin (MLB), Suzann Pettersen (LPGA), Matt Ryan (NFL), Vincent Lecavalier (NHL) and Nutritionist Elaine Hastings.

Read more:
Liquid Nutrition Signs Trish Stratus To Team Liquid

Longevity Global Inc. Gives The Proof Of Their Modern Engineering Standards By Launching A New Range Of …

Posted on by

Longevity Global Inc. has now launched the most advanced models of Welding Machines. The modern engineering that has been applied on these new welding devices give the proof that why Longevity is the most dominant player in the welding industry. The new models of Tig Welders, Mig Welders and other muti-purpose units manufactured launched by Longevity Global Inc. has surpassed their own previous standards.

Hayward, CA (PRWEB) October 11, 2012

President of Longevity global Inc. Simon Katz took the dice to make an announcement. He stated, Technology would never cease to modernize. At Longevity, we understand the continuous changing needs of welding factories and keeping that into consideration our highly qualified technical team members are always proactive to design technologically advanced machines and accessories. We believe in delivering the Welding Supplies which are futuristic in design and efficient in performance. Our new range of welding machines can meet the needs of all possible welding jobs. All our valued customers can expect these kind of amazing launches as we believe doing all the hard yards and strive to fulfill the all the requirements of the welding factories.

Longevity Global Inc. is USA's leading cutting and welding equipment supplier. The company also targets to meet the power backup needs of homes and commercial places with their power generators. Longevity offers a full line of welding equipment for both Do-It-Yourself (DIY) and professional welding purposes. All of their equipment comes with an unmatched warranty of 5-Years on both parts and labor. Through innovation, experience, and engineering, they provide customer with affordable and reliable welding machines in all ranges of production from the garage users, to pipe welders, and ship builders.

About the company:

Longevity Global Inc. is providing its dedicated service since 2001. It is growing at a phenomenal pace with high customer satisfaction, innovative products and efficient industrial production. It works in different parts of world with distributors in Canada, Mexico, Brazil, Australia, United Kingdom, and other countries. Longevity Welding serves globally with manufacturing facilities with its logistic companies to effectively distribute products in a punctual and effective manner. To know more visit http://www.longevity-inc.com

Simon Katz Longevity, Inc. 1.877.566.4462 Email Information

Continued here:
Longevity Global Inc. Gives The Proof Of Their Modern Engineering Standards By Launching A New Range Of ...

US panel urges end to secret DNA testing over privacy concerns

Posted on by

They're called discreet DNA samples, and the Elk Grove, California, genetic-testing company easyDNA says it can handle many kinds, from toothpicks to tampons.

Blood stains from bandages and tampons? Ship them in a paper envelope for paternity, ancestry or health testing. EasyDNA also welcomes cigarette butts (two to four), dental floss ("do not touch the floss with your fingers"), razor clippings, gum, toothpicks, licked stamps and used tissues if the more standard cheek swab or tube of saliva isn't obtainable.

If the availability of such services seems like an invitation to mischief or worse - imagine a discarded tissue from a prospective employee being tested to determine whether she's at risk for an expensive disease, for instance - the Presidential Commission for the Study of Bioethical Issues agrees.

On Thursday it released a report on privacy concerns triggered by the advent of whole genome sequencing, determining someone's complete DNA make-up. Although sequencing "holds enormous promise for human health and medicine," commission chairwoman Amy Gutmann told reporters on Wednesday, there is a "potential for misuse of this very personal data."

"In many states someone can pick up your discarded coffee cup and send it for (DNA) testing," said Gutmann, who is the president of the University of Pennsylvania.

"It's not a fantasy to think about how, without baseline privacy protection, people could use this in a way that would be really detrimental," such as by denying someone with a gene that raises their risk of Alzheimer's disease long-term care insurance, or to jack up life insurance premiums for someone with an elevated genetic risk of a deadly cancer that strikes people in middle age.

"Those who are willing to share some of the most intimate information about themselves for the sake of medical progress should be assured appropriate confidentiality, for example, about any discovered genetic variations that link to increased likelihood of certain diseases, such as Alzheimer's, diabetes, heart disease and schizophrenia," Gutmann said.

The commission took on the issue because whole genome sequencing is poised to become part of mainstream medical care, especially by personalizing medical treatments based on a patient's DNA.

$1,000 genome

That has been driven in large part by dramatic cost reductions, from $2.5 billion per genome in the Human Genome Project of the 1990s and early 2000s to $1,000 soon. Several companies, including Illumina Inc. and Life Technology's Ion Torrent division, sell machines that can sequence a genome for a few hundred dollars, but that does not include the analysis to figure out what the string of 3 billion DNA "letters" means.

Read the original post:
US panel urges end to secret DNA testing over privacy concerns

Posted in DNA